Moderna, Inc. (MRNA) Insider Trading

Healthcare · Biological Products, (No Diagnostic Substances)

Open-market and disclosed Form 4 insider trading for Moderna, Inc. (MRNA) on InvestAtlant.

Recent insider transactions

DateInsiderTitleTypeValue
2026-10-15 Hoge Stephen President Sale $8.64M
2026-10-14 Hoge Stephen President Sale $96.4K
2026-10-14 Hoge Stephen President Sale $8.28M
2026-09-15 Hoge Stephen President Sale $5.88M
2026-09-14 Hoge Stephen President Sale $5.81M
2026-09-10 Mock James M Chief Financial Officer Sale $2.67M
2026-09-10 Mock James M Chief Financial Officer Sale $2.02M
2026-09-01 Klinger Shannon Thyme Chief Legal Officer Sale $485.8K

US equities research

Follow the money behind the market.

Public filings. Connected research. One workspace.

Click a source to open it in the workspace

InvestAtlant connects public filings, institutional activity, insider trades, congressional disclosures, and sector data to surface emerging market signals.

Signals

Where the market starts to move.

Detect emerging patterns, convergence, and divergence before they become obvious.

How it works

Three steps. From data to insight.

  1. Find

    Research stocks, investors, sectors, and politicians.

  2. Track

    Follow capital flows across sectors and filings.

  3. Detect

    Spot emerging alignment and divergence.

Fundamentals · Market context · Institutions · Insiders · Sectors · SEC filings

Open the research workspace.

Holdings from SEC 13F. Insider trades from Form 4. Congress from House and Senate PTRs. Real-time market prices via TradingView.